Macquarie University Hospital

Sydney 2109

1 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumors, Carcinoma, Pancreatic Ductal, Urinary Bladder Neoplasms, mCRPC

Studies at this site

• A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors — Recruiting now
• A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy — Running, not enrolling
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• Senaparib in mCRPC Patients With Homologous Recombination Repair Gene Alterations After Docetaxel Treatment — Status unconfirmed